English
BMKCloud Log in

About Us

Biomarker Technologies (BMK)

Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.

1 (1)
1 (2)
1 (3)
1 (4)

Our Platforms

Leading, Multi-level High-throughput Sequencing Platforms

PacBio platforms: Sequel II, Sequel, RSII

Nanopore platforms: PromethION P48, GridION X5 MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+

Professional, Automatic Molecular Laboratory

Over 20,000 square feet place

Advanced biomolecular laboratory instruments

Standard labs of sample extraction, library construction, clean rooms, sequencing labs

Standard procedures from sample extraction to sequencing under strict SOPs

Multiple and flexible experimental designs fulfilling diverse research goals

Reliable, Ease-to-use On-line Bioinformatic Analysis Platform

Self-developed BMKCloud platform

CPUs with 41,104 memory and 3 PB total storage

4,260 computing cores with peak computing power over 121,708.8 Gflop per second.

For inquiries about our products or pricelist, please leave your email to us.
We will be in touch within 24 hours.
Inquiry Now

Send your message to us:

Hit enter to search or ESC to close